Matches in Wikidata for { <http://www.wikidata.org/entity/Q86529028> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q86529028 description "artículu científicu espublizáu n'abril de 2013" @default.
- Q86529028 description "im April 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86529028 description "scientific article published on 01 April 2013" @default.
- Q86529028 description "wetenschappelijk artikel" @default.
- Q86529028 description "наукова стаття, опублікована у квітні 2013" @default.
- Q86529028 description "գիտական հոդված հրատարակված 2013 թվականի ապրիլի 1-ին" @default.
- Q86529028 name "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 name "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 type Item @default.
- Q86529028 label "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 label "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 prefLabel "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 prefLabel "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 P1433 Q86529028-92822FBB-81E5-4BCC-8AE1-7B4472487B7E @default.
- Q86529028 P1476 Q86529028-82E6C5D3-01F7-4BAE-8666-C9BF9620D805 @default.
- Q86529028 P2093 Q86529028-0C8CE961-C627-4B12-A38E-925A2A841458 @default.
- Q86529028 P2093 Q86529028-238FB64F-A24D-46E7-B03E-147DE5126592 @default.
- Q86529028 P2093 Q86529028-CA1AD3BD-38EF-41A7-9955-61BC5877F630 @default.
- Q86529028 P2093 Q86529028-FEED6964-64BC-4AD4-B7A4-C359B3D24B6C @default.
- Q86529028 P304 Q86529028-78718169-5668-4EFC-926C-0798E4502D94 @default.
- Q86529028 P31 Q86529028-5EF7BBF0-D6C8-4C20-A52E-AE6B584354A4 @default.
- Q86529028 P356 Q86529028-D0371F9C-25CD-4380-8D35-A489B4930631 @default.
- Q86529028 P433 Q86529028-D198AACA-26AA-4357-AEAD-4BC4E7B15E7D @default.
- Q86529028 P478 Q86529028-4540E838-CA91-4039-A153-7757A5DE2EAC @default.
- Q86529028 P577 Q86529028-F22DA9B3-379A-4956-B326-1002158D970F @default.
- Q86529028 P698 Q86529028-84478CF1-308D-46A8-98D8-3457CE5C68AD @default.
- Q86529028 P921 Q86529028-25E4FB0C-F684-4791-9208-AA8887B035AC @default.
- Q86529028 P921 Q86529028-61441AE5-3E31-43A5-8EE5-E76B6FB1102D @default.
- Q86529028 P356 AOS.12090 @default.
- Q86529028 P698 23551594 @default.
- Q86529028 P1433 Q15716498 @default.
- Q86529028 P1476 "Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab" @default.
- Q86529028 P2093 "Greet Dijkman" @default.
- Q86529028 P2093 "Gré P M Luyten" @default.
- Q86529028 P2093 "Martine J Jager" @default.
- Q86529028 P2093 "Stefan J R de Geus" @default.
- Q86529028 P304 "e411-3" @default.
- Q86529028 P31 Q13442814 @default.
- Q86529028 P356 "10.1111/AOS.12090" @default.
- Q86529028 P433 "5" @default.
- Q86529028 P478 "91" @default.
- Q86529028 P577 "2013-04-01T00:00:00Z" @default.
- Q86529028 P698 "23551594" @default.
- Q86529028 P921 Q27429789 @default.
- Q86529028 P921 Q413299 @default.